Concepedia

Publication | Open Access

Macrophage Exclusion after Radiation Therapy (MERT): A First in Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma

DOIFull Paper Access

96

Citations

45

References

2019

Year

Reena Thomas, Seema Nagpal, Michael Iv, Scott G. Soltys, Sophie Bertrand, Judith S. Pelpola, Robyn L. Ball, Jaden Yang, Vandana Sundaram, Sophia B. Chernikova,
Clinical Cancer Research

Abstract

Infusion of the CXCR4 inhibitor plerixafor was well tolerated as an adjunct to standard chemoirradiation in patients with newly diagnosed GBM and improves local control of tumor recurrences.

References

YearCitations

Page 1